Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/30/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Lee B. Riley

Wrong Dr. Lee B. Riley?

Medical Director, Cancer Center

Local Address: Allentown, Pennsylvania, United States
St. Luke's Hospital
 
Background

Employment History

  • Medical Director, Oncology Services
    St. Luke's Hospital
  • Medical Director of Oncology and Director of Surgical Research
    St. Luke's Hospital
  • Owner
    Cancer Immunotherpies, LLC

Board Memberships and Affiliations

  • Board Member
    Cancer Support Community

Education

  • MD
  • PhD
  • medical degree
    University of Texas Medical School at Houston
  • Doctor of Philosophy degree , immunology
    University of Texas Graduate School of Biomedical Sciences
113 Total References
Web References
Lee B. Riley, MD, PhD, ...
www.slhn.org, 30 Jan 2014 [cached]
Lee B. Riley, MD, PhD, FACS Surgical Oncology
Medical Director, St. Luke's Cancer Center
...
More about Dr. Riley
Dr. Lee B. ...
www.slhn.org, 5 April 2011 [cached]
Dr. Lee B. Riley
...
"The money we raise will be invested in educating and building awareness about skin cancer, especially melanoma, as well as critical research efforts to cure melanoma," explained Dr. Lee B. Riley, Medical Director, Oncology Services, St. Luke's Hospital & Health Network.
...
"Everyone needs to be aware of melanoma," commented Dr. Riley, "because it is usually curable if caught early. Early stage melanoma has an overall 90% survival rate."
Chris Fazio, chair of the Susan Fazio Foundation, stated, "Our partnership with Dr. Riley, Dr. Agarwala and St. Luke's Hospital highlights the need to do much, much more to bring the facts about melanoma to more and more people.
Above, Dr. Riley holds the ...
www.slhn.org, 10 Jan 2011 [cached]
Above, Dr. Riley holds the newest Illumina chip being used in the St. Luke's Cancer Research
...
in this field, according to Dr. Riley.
Bethlehem, PA (1/10/2011) - Recently, a very unique and exciting piece of equipment called the IlluminaBeadArray Reader was purchased for St. Luke's Cancer Research Lab. It's an innovative technology that will position St. Luke's as the region's leading hospital involved with translational cancer research, according to Lee B. Riley, MD, PhD, FACS, Medical Director of Oncology and Director of Surgical Research for St. Luke's Hospital & Health Network.
The key is gene-chip technology. This fully confocal microarray scanning system works in concert with IlluminaBeadChips, giving researchers the ability to scan Infinium and GoldenGate Genotyping products. "Amazingly, the one-inch gene-chip can evaluate the expression of all 25,000 human genes from a sample," says Dr. Riley.
The completion of the human genome project changed the research world over the last decade. "Now this equipment, coupled with gene-chip technology, is changing the clinical world as well," says Dr. Riley. "Importantly, the knowledge gained from genomic research can lead to scientific discoveries and clinical applications that may ultimately reduce cancer incidence and improve survivorship."
Sampling the tumor bank for genomic clues
This past year, St. Luke's piloted a program to acquire and preserve nucleic acids (both DNA and RNA) from patients' tumors. "This limited tumor bank is now being extended to a larger set of patients," says Dr. Riley. "Additionally, we have started extracting RNA from cancer samples stored in paraffin. Because St. Luke's preserves cancer samples for 10 years, we have access to the 'genomic finger prints' of an estimated 20,000 cancers."
The potential to extract genomic info rmation from over 20,000 cancers and 10-year cancer-outcome data, including survival and recurrence data, provides St. Luke's with an immense research resource. "Over the past six months, we have demonstrated we can extract and preserve the genetic material from fresh and preserved cancer tissue," says Dr. Riley. "We are now poised to utilize the gene-chip equipment."
St. Luke's is a community facility and follow-up clinical info rmation has been superb. "It's worth noting St. Luke's cancer program received the highest honor from the American College of Surgeons for the quality of their clinical follow-up," says Dr. Riley.
...
"Now that this equipment is on site, we will be able to save considerably by not outsourcing our genomic material at the current cost of $2,000 per patient," says Dr. Riley.
Cancer Support Community - Greater Lehigh Valley - About Us
www.cancersupportglv.org, 7 May 2014 [cached]
Lee B. Riley, MD, PhD
...
Lee Riley, MD, PhD
"We are thrilled to have these ...
www.slhn.org, 1 Mar 2013 [cached]
"We are thrilled to have these programs available not only to our cancer patients, but anyone affected by cancer, and thankful to the Cancer Support Community and a very special St. Luke's benefactor, Mrs. Elaine Emrick, for making it possible," says Lee B. Riley, MD, PhD, FACS, Medical Director, Oncology Services, St. Lukes' University Health Network. Dr. Riley also serves on the Board of the Cancer Support Community of the Greater Lehigh Valley.
Other People with the name "Riley":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304